NCT06931717
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06931717 |
| Title | A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy. (ARCH) |
| Acronym | ARCH |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | ETOP IBCSG Partners Foundation |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA | IRL | FRA | EST | ESP | DEU | CHE | AUT |
CKB BOOST